Phibro Animal Health (PAHC) CFO sells 840 shares to cover taxes

Rhea-AI Filing Summary

Phibro Animal Health’s Chief Financial Officer David Glenn reported an other disposition of 840 shares of Class A Common Stock on 2026-08-04 at an average price of $36.599 per share. These shares were sold in a broker-assisted cashless exercise to satisfy tax withholding upon vesting of restricted stock units, leaving him with 51,477 shares directly owned.

Insider Trade Summary

Net Seller: 840 shares

Net Sell 1 txn

Insider David Glenn

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Other	Class A Common Stock F1	840	$36.599	$31K

Holdings After Transaction: Class A Common Stock — 51,477 shares (Direct)

Footnotes (1)

1. F1. Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.

Key Figures

Shares disposed: 840 shares Average price per share: $36.599 per share Shares owned after transaction: 51,477 shares

3 metrics

Shares disposed 840 shares Class A Common Stock disposed on 2026-08-04

Average price per share $36.599 per share Price for 840 shares disposed on 2026-08-04

Shares owned after transaction 51,477 shares Directly owned Class A Common Stock following disposition

Key Terms

broker assisted cashless exercise program, tax withholding obligations, restricted stock units

3 terms

broker assisted cashless exercise program financial

"Represents shares sold in a broker assisted cashless exercise program"

tax withholding obligations financial

"to satisfy tax withholding obligations upon the receipt of Class A Common"

restricted stock units financial

"in connection with the vesting and settlement of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/06/2026 - 08:12 PM Accepted by SEC EDGAR 08/06/2026 - 08:10 PM Learn about SEC filing dates

FAQ

What insider transaction did PAHC CFO David Glenn report?

David Glenn reported an other disposition of 840 shares of Phibro Animal Health Class A Common Stock. The shares were sold via a broker-assisted cashless exercise to cover tax withholding triggered by vesting restricted stock units.

At what price did PAHC CFO David Glenn dispose of shares?

The reported disposition was executed at an average price of $36.599 per share. This price applies to the 840 shares sold in a broker-assisted cashless transaction used specifically to satisfy tax withholding obligations on vested restricted stock units.

How many PAHC shares does CFO David Glenn hold after this transaction?

After the reported disposition, David Glenn directly owns 51,477 shares of Phibro Animal Health Class A Common Stock. The transaction only involved 840 shares, sold to cover tax withholding from restricted stock unit vesting.

Was the PAHC CFO’s August 4, 2026 transaction under a 10b5-1 plan?

The filing indicates the Rule 10b5-1 checkbox is not marked, so the reported transaction was not affirmed as occurring under a Rule 10b5-1 trading plan. It was tied instead to tax withholding on restricted stock unit vesting.

Why did PAHC CFO David Glenn sell 840 shares in this filing?

The 840 shares were sold in a broker-assisted cashless exercise program to satisfy tax withholding obligations. This occurred upon receipt of Class A Common Stock delivered in connection with the vesting and settlement of restricted stock units.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

David Glenn

(Last) (First) (Middle)

300 FRANK W. BURR BLVD., STE 21

(Street)

TEANECK NEW JERSEY 07666

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/04/2026		J		840(1)	D	$36.599	51,477	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.

	/s/ Judith Weinstein, as Attorney-in-Fact for Glenn David	08/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)